cyclic peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-22. Anything still debated is marked as such rather than presented as settled.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
compared four sterile wound-cleansing solutions (saline, Ringer's solution, Prontosan® and Octenisept®) using a wound coating model consisting of slides containing dried blood plasma or fibrin. The concentration of dissolved proteins was measured and the findings indicate that a surfactant containing solution (polyhexamethylene biguanide with betaine) (Prontosan®) was more effective than saline in removing the protein (adhered dried plasma or fibrin). The proteins in the antiseptic solution (Octenisept®) were denatured and became insoluble. The authors suggest this implies that the antiseptic solution is unsuitable as a 'general' wound cleanser and that its use should be restricted to infected wounds. In a double-blind, randomised, stratified, controlled, parallel-group study the influence of two antiseptics (octenidine, polyhexanide) versus a placebo of Ringer's solution on wound healing in a porcine model was conducted. Assessment of healing was recorded using planimetry and histopathology. At nine days post wounding, the octenidine-treated wounds demonstrated retarded contraction at significantly greater extent than placebo and polyhexanide. At days 18 and 28 the polyhexanide treated wounds supported contraction significantly more than placebo and octenidine. The polyhexanide treated wounds led to complete wound closure after 22.9 days, in comparison to the placebo octenidine treated wounds respectively, 24.1 days (p < 0.05) and 28.3 days (no statistical difference to placebo).
== Achievements == Pultronics has contributed to the design flow of integrated circuits. Through the development of TED, an EDA thermal analysis tool of ICs, Pultronics provided an additional layer of verification to integrated circuit design. What makes TED different from other similar tools is that the thermal analysis is based on the physical topology of the IC instead of its schematic entry. Pultronics has also contributed to the testing of integrated circuits with the development of independent modules that could be placed directly on the IC. Such modules typically provide valuable information on the performance of the IC without resorting to complex measurement setups. Traditional methods of IC testing can require measurement equipment which are costly (>10-100k$) and can also distort the measured information.
In the area of paper and paperboard manufacture, nanocelluloses are expected to enhance the fiber-fiber bond strength and, hence, have a strong reinforcement effect on paper materials. Nanocellulose may be useful as a barrier in grease-proof type of papers and as a wet-end additive to enhance retention, dry and wet strength in commodity type of paper and board products. Grease-proofness by using a mineral oil simulant (heptane) has been demonstrated using heptane vapor rate testing. It has been shown that applying CNF as a coating material on the surface of paper and paperboard improves the barrier properties, especially air resistance and grease/oil resistance. It also enhances the structure properties of paperboards (smoother surface). Very high viscosity of MFC/CNF suspensions at low solids content limits the type of coating techniques that can be utilized to apply these suspensions onto paper/paperboard. Some of the coating methods utilized for MFC surface application onto paper/paperboard have been rod coating, size press, spray coating, foam coating and slot-die coating. Wet-end surface application of mineral pigments and MFC mixture to improve barrier, mechanical and printing properties of paperboard are also being explored. Nanocellulose can be used to prepare flexible and optically transparent paper. Such paper is an attractive substrate for electronic devices because it is recyclable, compatible with biological objects, and easily biodegrades.
Pleasure promotes well-being as a positive feeling about what is attractive. Pain, by contrast, diminishes well-being as a negative feeling about what is aversive. Pleasure and pain are closely tied to the brain's reward system, influencing motivation and behavior by reinforcing beneficial actions and discouraging harmful ones. They shape how individuals perceive their lives and interact with their social and physical environments. Pleasure and pain are commonly seen as opposites that counterbalance each other. This view suggests that the negative value of experiencing intense pain can be compensated by the positive value of experiencing intense pleasure. A different perspective argues that their relation is more complex because they influence experience, motivation, and well-being in distinct ways that are not always symmetrical. Following this idea, one view holds that avoiding pain is more important than seeking pleasure. Pleasure and pain are often tied to emotions, which are temporary states of arousal, such as joy, hope, anger, and fear. Emotions include subjective experiences of pleasure and pain alongside other psychological phenomena, such as the evaluative assessment of a situation and a disposition to engage in certain types of behavior. For example, fear evaluates a situation as dangerous and is associated with a behavioral disposition to flee. Additionally, emotions are linked to physiological changes, like sweating, and bodily expressions that signal the emotional state to others.
== Personal life == Riff Raff has a large number of tattoos, including the logos for WorldStarHipHop, NBA, and MTV, which he had acquired during auditions for the 2009 reality TV show From G's to Gents. Previously, he had a BET tattoo on the front of his right shoulder, which was later covered up with a tattoo of his dog, "Jody Husky". He is a fan of The Simpsons, with a tattoo of Bart holding test tubes that reads "The Freestyle Scientist" on his chest. He also has a large gothic cross below his left shoulder, framed by a prayer that reads, "Dear Jesus, Please Let Me In. Your Child, Horst Simco."
Sources: en.wikipedia.org
== Toxicogenomics == Novo is involved in government funded collaborative research projects with other industrial and governmental partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox. The company is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of European Federation of Pharmaceutical Industries and Associations and the European Commission.
== D == DAIDS – data safety and monitoring board (DSMB) – deletion – dementia – demyelination – dendrite – dendritic cells – deoxyribonucleic acid (DNA) – Department of Health and Human Services (DHHS/HHS or DHHS) – desensitization – diabetes mellitus (DM) – diagnosis – diarrhea – diplopia – dissemination – division of acquired immunodeficiency syndrome (DAIDS) – DNA – dose-ranging study – dose-response relationship – double-blind study – drug resistance – drug-drug interaction – DSMB – Duffy antigen system – dysplasia – dyspnea
=== Alcohol === The removal of ethanol (drinking alcohol) through oxidation by alcohol dehydrogenase in the liver from the human body is limited. Hence the removal of a large concentration of alcohol from blood may follow zero-order kinetics. Also the rate-limiting steps for one substance may be in common with other substances. For instance, the blood alcohol concentration can be used to modify the biochemistry of methanol and ethylene glycol. In this way the oxidation of methanol to the toxic formaldehyde and formic acid in the human body can be prevented by giving an appropriate amount of ethanol to a person who has ingested methanol. Methanol is very toxic and causes blindness and death. A person who has ingested ethylene glycol can be treated in the same way. Half life is also relative to the subjective metabolic rate of the individual in question.
A series of four lectures, given by Thomson on a visit to Princeton University in 1896, were subsequently published as Discharge of electricity through gases (1897). He also presented a series of six lectures at Yale University in 1904.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.